Paul A. Friedman, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 47,947 shares at $555.39 ($26.5M) on 2025-12-10, disclosed to the SEC on 2025-12-12.
Scheduled sale ($26.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $547.75 | 624 | $342K | 1.3% |
| 2 | $548.51 | 535 | $293K | 1.1% |
| 3 | $548.51 | 535 | $293K | 1.1% |
| 4 | $549.99 | 409 | $225K | 0.8% |
| 5 | $549.99 | 409 | $225K | 0.8% |
| 6 | $550.93 | 4,316 |
| $2.4M |
| 9.0% |
| 7 | $550.93 | 4,316 | $2.4M | 9.0% |
| 8 | $551.67 | 7,193 | $4.0M | 15.0% |
| 9 | $551.67 | 7,193 | $4.0M | 15.0% |
| 10 | $552.74 | 5,533 | $3.1M | 11.6% |
| 11 | $552.74 | 5,533 | $3.1M | 11.6% |
| 12 | $553.83 | 5,001 | $2.8M | 10.5% |
| 13 | $553.83 | 5,001 | $2.8M | 10.5% |
| 14 | $555.00 | 1,029 | $571K | 2.2% |
| 15 | $555.39 | 160 | $89K | 0.3% |
| 16 | $555.39 | 160 | $89K | 0.3% |
| Total | $552.18 avg | 47,947 | $26.5M | 100% |
| Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |
| MDGL | SELL | 2025-07-22 | $980K | — | Filing → |